NCT03805191View on ClinicalTrials.gov

A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients

UnknownOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

December 30, 2022

Conditions
Type 2 Diabetes MellitusPoor Glycemic Control
Trial Locations (1)

Unknown

RECRUITING

Qilu Hospital of Shandong University, Jinan

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Qilu Hospital of Shandong University

OTHER

NCT03805191 - A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter